Back
KalVista Pharmaceuticals Vs. Digimarc Industry Stock Comparison
Sell
16
KALV
KalVista Pharmaceuticals
Last Price:
$8.84
Seasonality Move:
-3.06%
Buy
69
DMRC
Digimarc
Last Price:
$47.66
Seasonality Move:
-0.46%
Sell
16
KalVista Pharmaceuticals (KALV)
is a Sell
Is KalVista Pharmaceuticals a Buy, Sell or Hold?
-
The current KalVista Pharmaceuticals [KALV] share price is $8.68. The Score for KALV is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
-
KALV is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
KALV Stock Price Chart
What is KalVista Pharmaceuticals's stock price today?
-
The KalVista Pharmaceuticals share price today is $8.68The current trend is relatively stagnant and KALV is experiencing selling pressure, which indicates risk of future bearish movement.
DMRC Stock Price Chart
KALV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 44.39 | Sell |
Chaikin Money Flow: | -136645 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.45 - 9.53) | Sell |
Bollinger Bands (100): | (9.34 - 12.2) | Sell |
DMRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.6 | Buy |
Relative Strength Index (14 RSI): | 78.22 | Buy |
Chaikin Money Flow: | 85595 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.95 - 40.57) | Buy |
Bollinger Bands (100): | (27.05 - 35.65) | Buy |
KALV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.69 | Sell |
20-day SMA: | 8.8 | Sell |
50-day SMA: | 9.79 | Sell |
200-day SMA: | 11.49 | Sell |
8-day EMA: | 8.72 | Sell |
20-day EMA: | 8.9 | Sell |
50-day EMA: | 9.63 | Sell |
200-day EMA: | 10.99 | Sell |
DMRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.59 | Buy |
20-day SMA: | 37.98 | Buy |
50-day SMA: | 34.59 | Buy |
200-day SMA: | 29.38 | Buy |
8-day EMA: | 41.69 | Buy |
20-day EMA: | 38.66 | Buy |
50-day EMA: | 35.39 | Buy |
200-day EMA: | 31.4 | Buy |
KalVista Pharmaceuticals Earnings Growth & KALV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.61 per share, and an increase next year of $1.01 per share.
Digimarc Earnings Growth & DMRC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and a decrease next year of $0.00 per share.
KalVista Pharmaceuticals Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Digimarc Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |